Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Operates as a biotech company focused on cell fate control.
Year Established: | 2007 |
Funding: | 42 |
Address: | 3535 General Atomics Court Suite 200 San Diego, CA 92121 |
Telephone: | 2147483647 |
Mobile: | |
Fax: | |
Mail: | |
Company URL: | http://www.fatetherapeutics.com |
At Fate Therapeutics part of our pathways to success includes empowering remarkable individuals. We provide an environment that fosters collaboration and trust to ignite passion build insight and gain wisdom.
To be a part of our groundbreaking team please check our open positions often. For consideration please send your resume to us at
and reference the Job Code.
ARCH Venture Partners,Astellas Venture Capital (FKA: Yamanouchi Venture Capital),Genzyme Ventures,OVP Venture Partners,Polaris Venture Partners,Undisclosed Firm,Venrock Associates
PAUL GRAYSON
President and Chief Executive Officer
Mr. Grayson is the president and CEO of Fate Therapeutics. Mr. Grayson was previously managing director of Sanderling Ventures. Over the last ten years, he has completed both private and public capital fundraising, delivering more than $200 million for emerging companies. Transactions completed under Mr. Grayson